2-[2-(4-chlorophenyl)ethoxy]ethyl methanesulfonate | 81228-22-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-[2-(4-chlorophenyl)ethoxy]ethyl methanesulfonate
• CAS: 81228-22-0
• 化学式: C₁₁H₁₅ClO₄S
• 分子量: 278.757
• InChiKey: AAYYXQFVKKYUAA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  61
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-[2-羟基-3-(丙-2-基氨基)丙氧基]苯酚 、 2-[2-(4-chlorophenyl)ethoxy]ethyl methanesulfonate 以 乙酸乙酯 为溶剂， 以there were obtained 1.3 g (57%) of 1-[4-[2-(4-chlorophenethyloxy)-ethoxy]phenoxy]-3-isopropylamino-2-propanol hydrochloride of melting point 99°-101° C. (from ethyl acetate)的产率得到1-[4-[2-(4-chlorophenethyloxy)-ethoxy]phenoxy]-3-isopropylamino-2-propanol hydrochloride
  参考文献：
  名称：

  Substituted phenoxy-aminopropanols

  摘要：

  描述了公式##STR1##中R为3或4个碳原子的支链烷基，R.sup.1为氢，卤素或较低的烷基，R.sup.2和R.sup.3，独立地为氢，卤素，较低的烷基，较低的烷氧基或较低的烷硫基，以及其药学上可接受的酸加盐。还描述了它们的制备过程以及含有它们的药物制剂。公式I的化合物及其盐具有心脏选择性β-肾上腺素受体阻滞活性和降压活性。

  公开号：

  US04649160A1
• 作为产物：
  描述：

  4-氯苯乙醇 在 吡啶 、 lithium aluminium tetrahydride 、 sodium hydride 作用下， 以 四氢呋喃 为溶剂， 反应 1.67h， 生成 2-[2-(4-chlorophenyl)ethoxy]ethyl methanesulfonate
  参考文献：
  名称：

  .beta.1-Selective adrenoceptor antagonists. 2. 4-Ether-linked phenoxypropanolamines

  摘要：

  A series of 4-substituted phenoxypropanolamines was prepared and examined for beta-adrenoceptor activity. Some of the compounds, especially the [4-[2-[[2-(4-fluorophenyl)ethyl] oxy]ethoxy]phenoxy]propanolamines (14, 15, and 24), showed potent beta 1-blockade with virtually no beta 2-blockade at doses over a 1000 times greater. The compounds also possessed partial agonist activity. Structure-activity relationships are discussed, and conclusions are drawn about the binding sites on beta-adrenoceptors.

  DOI：

  10.1021/jm00365a005

文献信息

• Substituted phenoxy-aminopropanols
  申请人：Hoffmann-La Roche Inc.

  公开号：US04649160A1

  公开（公告）日：1987-03-10

  Substituted phenoxy-aminopropanols of the formula ##STR1## wherein R is a branched-chain alkyl of 3 or 4 carbon atoms, R.sup.1 is hydrogen, halogen or lower alkyl and R.sup.2 and R.sup.3, independently, are hydrogen, halogen, lower alkyl, lower alkoxy or lower alkylthio, and pharmaceutically acceptable acid addition salts thereof, are described. A process for their preparation, as well as pharmaceutical preparations containing them are also described. The compounds of formula I and their salts possess cardioselective .beta.-adrenergic blocking activity and antihypertensive activity.

  描述了式子##STR1##中R为3或4个碳原子的支链烷基，R.sup.1为氢、卤素或较低烷基，R.sup.2和R.sup.3独立地为氢、卤素、较低烷基、较低烷氧基或较低烷基硫基的苯氧基氨基丙醇衍生物，以及其药学上可接受的酸盐。还描述了一种制备它们的方法，以及含有它们的药物制剂。式I的化合物及其盐具有心脏选择性β-肾上腺素能受体阻滞活性和降压活性。
• US4649160A
  申请人：——

  公开号：US4649160A

  公开（公告）日：1987-03-10
• .beta.1-Selective adrenoceptor antagonists. 2. 4-Ether-linked phenoxypropanolamines
  作者：Peter J. Machin、David N. Hurst、Rachel M. Bradshaw、Leslie C. Blaber、David T. Burden、Allison D. Fryer、Rosemary A. Melarange、Celia Shivdasani

  DOI：10.1021/jm00365a005

  日期：1983.11

  A series of 4-substituted phenoxypropanolamines was prepared and examined for beta-adrenoceptor activity. Some of the compounds, especially the [4-[2-[[2-(4-fluorophenyl)ethyl] oxy]ethoxy]phenoxy]propanolamines (14, 15, and 24), showed potent beta 1-blockade with virtually no beta 2-blockade at doses over a 1000 times greater. The compounds also possessed partial agonist activity. Structure-activity relationships are discussed, and conclusions are drawn about the binding sites on beta-adrenoceptors.
• MACHIN, P. J.;HURST, D. N.;BRADSHAW, R. M.;BLABER, L. C.;BURDEN, D. T.;FR+, J. MED. CHEM., 1983, 26, N 11, 1570-1576
  作者：MACHIN, P. J.、HURST, D. N.、BRADSHAW, R. M.、BLABER, L. C.、BURDEN, D. T.、FR+

  DOI：——

  日期：——